Article Information
History
- September 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aoji Xie1,
- Elizabeth Ensink1,
- Peipei Li1,
- Juozas Gordevičius1,
- Lee L. Marshall1,
- Sonia George1,
- J. Andrew Pospisilik2,
- Velma T. E. Aho3,4,
- Madelyn C. Houser5,6,
- Pedro A. B. Pereira3,4,
- Knut Rudi7,
- Lars Paulin4,
- Malú G. Tansey6,8,
- Petri Auvinen4,
- Patrik Brundin1,9,
- Lena Brundin1,9,
- Viviane Labrie1,9,* and
- Filip Scheperjans3,*,#
- 1Parkinson’s Disease Center, Department for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, 49503 USA
- 2Center for Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503 USA
- 3Department of Neurology, Helsinki University Hospital, and Clinicum, University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland
- 4Institute of Biotechnology, DNA Sequencing and Genomics Laboratory, University of Helsinki, Viikinkaari 5D, 00014 Helsinki, Finland
- 5Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA 30322, USA
- 6Department of Physiology, Emory University School of Medicine, 615 Michael St, Atlanta, GA 30322, USA
- 7Faculty of Chemistry, Biotechnology and Food Science (KBM), Norwegian University of Life Sciences, 1433 Oslo, Ås, Norway
- 8Department of Neuroscience and Neurology, Center for Translational Research in Neurodegenerative Disease, University of Florida College of Medicine, 1149 Newell Dr., Gainesville, FL 32611, USA
- 9Division of Psychiatry and Behavioral Medicine, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503 USA
- ↵# Corresponding author; email: filip.scheperjans{at}hus.fi
Posted September 22, 2021.
Butyrate and related epigenetic changes link Parkinson’s disease to inflammatory bowel disease and depressive symptoms
